Israeli pharmaceuticals company NeuroDerm Ltd. (Nasdaq: NDRM) has been sold for $1.1 billion in cash ($39 per share). This is the largest ever acquisition of an Israeli healthcare company, and one of the largest acquisitions of an Israeli company of any kind.
The buyer, in the largest ever acquisition of an Israeli pharmaceuticals company, is Japan’s Mitsubishi Tanabe Pharma Corporation.
NeuroDerm is a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders. Read more here.